On September 4, 2026, Medicus Pharma Ltd. issued an aggregate of 8,529,412 restricted common shares to certain officers and employees in lieu of cash bonuses totaling approximately $1.45 million. The share count was calculated by dividing the bonus amounts by the closing price of $0.1705 per share on September 3, 2026. No additional consideration was paid or received by the company for this issuance, which was exempt from registration under Section 4(a)(2) of the Securities Act of 1933 as a private transaction not involving a public offering. Medicus Pharma Ltd. operates in the pharmaceutical industry, focusing on the development and commercialization of drug products.